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Abstract: Streptomyces albus J1074 is recognized as an effective host for heterologous production of
natural products. Its fast growth and efficient genetic toolbox due to a naturally minimized genome
have contributed towards its advantage in expressing biosynthetic pathways for a diverse repertoire
of products such as antibiotics and flavonoids. In order to develop precise model-driven engineering
strategies for de novo production of natural products, a genome-scale metabolic model (GEM) was
reconstructed for the microorganism based on protein homology to model species Streptomyces
coelicolor while drawing annotated data from databases and literature for further curation. To
demonstrate its capabilities, the Salb-GEM was used to predict overexpression targets for desirable
compounds using flux scanning with enforced objective function (FSEOF). Salb-GEM was also utilized
to investigate the effect of a minimized genome on metabolic gene essentialities in comparison to
another Streptomyces species, S. coelicolor.
Keywords: genome-scale metabolic model; Streptomyces albus J1074; heterologous production; natural
products; gene essentiality; minimized genome
1. Introduction
The use of actinomycete microbial cell factories has been paramount to the industrial-
ization of bioactive compounds. Possessing all the essential metabolic components and
biosynthetic machinery required for their production and proper modification (e.g., post-
translational modification by CYP450 enzymes or phosphopantetheinyl transferases needed
for proper function of polyketide synthases and non-ribosomal peptide synthetases), acti-
nomycetes produce among the most diverse array of compounds [1–3]. Within this group
of microorganisms, Streptomyces albus J1074 is commonly utilized as a microbial host for
the heterologous production of bioactive natural products and secondary metabolites [4–6].
Two main factors culminating in preferential use of S. albus in biotechnological applications
are its fast growth and an efficient genetic toolbox, which have proven it advantageous
as a platform for product discovery and heterologous production [7]. S. albus J1074 was
initially isolated as a derivative of the S. albus strain G defective in the SalI restriction-
modification system [8], which enabled the relatively straightforward genetic manipulation
of the microorganism. Moreover, this streptomycete has relatively dispersed mycelial
growth contrasting with the more common dense mycelial aggregation found in other
species, which allows for better scaling up in an industrial setting.
There have been numerous endeavors to engineer S. albus J1074 (hereafter referred
to solely as S. albus) to facilitate production of valuable compounds. The strain has been
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used for the heterologous expression of secondary biosynthetic gene clusters (BGC) taken
from both Streptomyces and non-genus species such as the thiocoraline BGC from marine
Micromonospora [9]. S. albus has been shown to harbor 22 BGCs, but clusters mostly re-
main cryptic (i.e., not expressed) across all stages of its growth in conventional liquid
media [7,10–12]. Of the compounds known to be produced by S. albus, paulomycins
are the only identified antibacterial compounds and their production remains highly un-
stable [13–16]. The known antifungal compounds produced endogenously consist of
candicidins, antimycins, alteramides and surugamides [17]. Recently, it was also revealed
that certain media such as SG2 was able to enhance production of these secondary metabo-
lites [18], which was attributable to the overall increased transcriptional activity evidenced
by RNA-seq studies on the organism grown in both SG2 and the more conventional TSB
media. Additionally, novel strains of S. albus have been constructed with their native
biosynthetic gene clusters removed [10], consequently leading not only to better compound
detection (due to no background from endogenous secondary metabolites) but also to over-
all higher production yields compared to the ancestor S. albus strain and other S. coelicolor
hosts. S. albus has been used to heterologously produce natural products including various
types of flavonoids [19], and S. albus has been demonstrated to produce the flavonols
myricetin, kaempferol and quercetin more efficiently than S. coelicolor [20].
However, despite the numerous studies on S. albus, there persists a lack of knowledge
on how to best engineer the microbial host through a holistic approach. In order to glean a
systems-level understanding of the metabolic potential of S. albus, a mathematical model
of the organism metabolism can be developed and utilized. A genome-scale metabolic
model (GEM) is a network-wide representation of the metabolism of the cell or microor-
ganism [21,22]. GEMs serve as invaluable databases constructed from genome annotation,
either inferentially or through experimentally validated gene-protein-reaction (GPR) rela-
tionships. This network connecting reactions and metabolites is mathematically delineated
within a stoichiometric matrix. With the matrix as the main component, GEMs can be used
as mathematical models to compute steady-state flux distributions and therefore predict
phenotypes of the organism under different conditions. Furthermore, the GEM can be used
as a canvas of sorts to contextualize “omics” data (e.g., proteomics, transcriptomics, and
metabolomics) to derive further meaningful insights.
In order to further drive the engineering of S. albus as a chassis for heterologous
compound production, understanding its capabilities and metabolism at the systems-wide
level will yield insights by both integrating the current knowledge of the organism and
informing new design strategies. To this end, the first GEM for S. albus J1074—herein de-
noted as Salb-GEM—was developed using Sco-GEM [23], a high-quality manually curated
GEM for S. coelicolor (the most genetically well understood representative of the genus)
as a template. In order to establish the use of this metabolic network reconstruction in
metabolic engineering, this study assesses its capabilities relative to its reference model
developed for S. coelicolor and demonstrates its applications in predicting gene targets for
overproduction of target compounds.
2. Results and Discussion
2.1. Reconstruction of Draft Genome-Scale Model
Salb-GEM is based on the genome sequence of S. albus strain J1074. The reconstruc-
tion steps (Figure 1) leading up to the release of this model were carried out using the
RAVEN toolbox [24,25], a MATLAB suite developed predominantly for genome-scale
model reconstruction and constraint-based analysis.
To first reconstruct the components of metabolism conserved among actinomycetes [26]
or more specifically within the genus Streptomyces, the high-quality consensus GEM [23] of
S. coelicolor, Sco-GEM, was referenced as a template model. Based on protein homology
evaluated by bi-directional protein blast (BLASTp) between S. albus and S. coelicolor [27], a
set of reactions associated with the identified orthologs was incorporated from Sco-GEM to
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form the initial draft network reconstruction of Salb-GEM. At this stage, 1645 metabolic
reactions associated with 1278 genes were included into the initial model.
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using the RAVEN Toolbox with a protein FASTA of the Streptomyces albus J1074 genome and Sco-GEM as a template model.
After manual curation and gap-filling of the metabolic network, additional genes and reactions specific to S. albus were
incorporated externally from KEGG based on trained hidden Markov models (HMMs). Salb-GEM is distributed openly on
GitHub, a version control and software development platform. (b) distribution of reactions sorted by metabolic subsystems.
Subsequently, transport and spontaneous reactions with no specified gene associations
were transferred from Sco-GEM to the draft model. Among these were exchange reactions
and pseudo-reactions that contribute towards the representation of biomass within the
model. Any reactions from this particular step that were disconnected from the remainder
of the metabolic network wer subsequently checked for and remov d.
The resulting model remained unable to support growth via production of biomass.
Consequently, gap-filling was implemented using the RAVEN toolbox, where a minimal
number of reactions was transferred from the template model to enable the production
of biomass components. From this step, an additional 18 genes and 119 reactions were
incorporated into the model. A significant portion of these reactions did not have any
exp cit gene associations in the template model and were, therefore, not considered in
the earlier semi-automated reconstruction steps. F r ex mple, myc thiol reductase is an
essential reaction in thiol redox metabolism, which in Streptomyces involves the unique thiol
mycothiol, and would therefore logically be part of the metabolic network reconstruction.
However, the gene responsible for the enzymatic activity has not yet been experimentally
verified and therefore remains in the model without gene association. A vast majority of
these non-gene associated reactions that were added to the model were involved in lipid
biosynthesis and fatty a id metabolism with multiple reactions corresponding to different
levels of fatty acid chain saturati n. In addition, the gap-filling identified reactions that
were not captured in the first reconstruction steps, such as ATP synthase, as the stringent
BLASTp parameters prevented matching of any subunits that were below the minimum
length assigned. The resulting draft model was thereby able to produce all required
biomass precursors.
2.2. Further Curation towards Salb-GEM
Following generation of the draft model, reactions and pathways specific to S. albus
were incorporated in the model, thereby differentiating it from existing Streptomyces models.
While there is little detailed and extensive knowledge of S. albus specific pathways available
in literature, we applied an approach where hidden Markov models (HMMs) trained on
the KEGG database [24] were used to query all S. albus proteins, and reactions associated
with genes that were not already included in the draft model were thereby introduced.
Through this process, 104 genes associated with 107 reactions were added to the metabolic
network reconstruction. Although it is imperative for the GEM to provide a description of
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metabolism that is as comprehensive as possible, the majority of secondary metabolites and
their associated pathways in S. albus remain relatively uncharacterized. While sequencing
of the genome has revealed 22 BGCs, many of these clusters remain cryptic, typically
silenced in conventional laboratory growth conditions [4,5,7]. As a result, the pathways
associated with these clusters have yet to be elucidated for the various biochemical steps
and precursors involved in product synthesis of a given cluster.
Nonetheless, there have been experimental studies on the paulomycin BGC [13,28]
that were able to provide detailed evidence towards its incorporation into the metabolic
network reconstruction. S. albus produces the glycosylated antibiotics paulomycin A,
B and E from activity of the paulomycin BGC. The pathway has been investigated by
inactivation of genes encoding various enzymes, which are mainly involved in either
transfer of glycosyl/acyl moieties or the biosynthesis of paulic acid and paulomycose. The
study by Gonzalez et al. [14] has enabled the assignment of the genes to the individual
steps along the biosynthetic pathway based on identification of products and intermediates
accumulated in mutant strains defective in the aforementioned enzymatic steps. With this
information on the proposed pathway steps and annotations also derived from KEGG, the
corresponding reactions of the paulomycin pathway were manually introduced into the
metabolic network reconstruction.
These various reconstruction steps culminated in the genome-scale model Salb-GEM
comprising 2231 metabolic reactions, 1872 metabolites and 1381 genes (Table S1). The model
is distributed through and maintained on a dedicated repository on GitHub (https://www.
github.com/SysBioChalmers/Salb-GEM (accessed on 21 April 2021)), enabling open and
reproducible curation and development, and allowing the issue of updated releases.
Within Salb-GEM, 126 reactions, 112 metabolites and 120 genes were exclusive to
S. albus (i.e., not based on protein homology to S. coelicolor) as they were drawn from KEGG
and manual curation of secondary metabolite pathways (e.g., paulomycin), indicating an
anticipated significant overlap of metabolic pathways but also species-specific functionality.
When referencing the pan-genome established for 17 Streptomyces species [29], 561 of
the 1381 genes (40.6%) in Salb-GEM were part of the Streptomyces accessory genome. While
the core genome denotes the portion of genes conserved among the 17 Streptomyces species,
the accessory genome consists of genes whose presence differs considerably among Strepto-
myces species and confers upon them various advantageous traits to their environmental
niches, generally providing functions that were not necessarily essential for viability. These
561 genes are associated to 729 reactions, with a majority of these reactions involved in
secondary metabolism. With Salb-GEM containing a large fraction of accessory genes,
it comprises substantially more than merely the conserved core metabolic pathways of
Streptomyces but also acknowledges the diversity across species [30].
In addition to the inclusion of metabolic reactions, some of the macromolecule compo-
nents (e.g., the protein, DNA and RNA pseudo-reactions) of the biomass reactions were
successfully tailored based on the available genome and proteome of S. albus, while cellular
DNA and protein content was measured as 0.035 and 21.95 (g/gDW), respectively, from
an S. albus cultivation described below. However, to date no information is available on
the contribution of other components to S. albus biomass including the composition of
carbohydrate, lipid and any miscellaneous components that would need to be measured in
relation to the total mass of the cell (as % of cell dry weight) before inclusion in the biomass
reactions. Consequently, these macromolecular components of the biomass were assumed
to be identical with S. coelicolor and therefore inferred from the Sco-GEM model.
2.3. Calibrating Energetic Parameters from Cultivations
To equilibrate the energy requirements of S. albus [31], a time-course cultivation
of S. albus strain J1074 was performed, where glucose and biomass concentrations were
monitored over 72 h (Figure 2a). The measurements from t = 18 h until t = 48 h were selected
due to the clear trend of glucose consumption by an increasing cell mass. From combining
these measurements transpired a biomass yield of 24.7 mmol glucose per 1 g dry cell
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weight (Figure 2b). Consequently, in Salb-GEM a glucose influx of 1 mmol/gDWh should
result in a growth rate of 0.04 h−1. To equilibrate the model, the growth associated energy
cost (GAEC) and non-growth associated maintenance (NGAM) can be fitted. While the
exact distribution of energy costs across GAEC and NGAM could not be determined with
the currently available experimental data, we were able to determine which combination
of these energetic parameters result in the observed growth rate (Figure 2c). An NGAM
of 6.86 mmol/gDCW/h and corresponding GAEC of 173 mmol/gDCW were selected to




Figure 2. Cultivation data of S. albus J1074 grown on NL333 medium. (a) concentrations of dry cell weight of biomass (blue)
and glucose (orange) in media sampled every 6 h over 72 h. (b) a plot of the recorded glucose levels (in mmol/L) and the
corresponding biomass (in g/L) provides an estimate of the biomass yield. (c) comparison of deviations of predicted growth
rates relative to the expected value of 0.04 h−1 across a combination of tested NGAM and GAEC values. Deviations within
100% of the expected value are shown in color.
2.4. Functional Comparison to Sco-GEM Reference Model
While S. albus and S. coelicolor are closely related, there are also profound differences
in their genome and metabolism. S. albus has a smaller genome in comparison with
S. coelicolor, containing 5832 and 7769 coding sequences respectively. Indeed, S. albus
has among one of the smallest Streptomyces genomes at 6.84 Mbp while the size of the
genome of S. coelicolor is 8.67 Mbp. A closer look into the genomic sequence also revealed
that S. albus has a reduced number of orthologous group of genes. Furthermore, the
single chromosome-based genome of S. albus encodes for seven rRNA operons contrary
to the typical six associated with most Streptomyces species [7,32], which could possibly
expound its fast growth rate. Such features have contributed to its use as a platform for
heterologous production.
However, Salb-GEM has a slightly higher genomic coverage at 23.6% (with 1381 genes
in the model) relative to the latter at a coverage of 22.9% (with 1777 genes), indicating
the genome reduction in S. albus is not differentially affecting the number of metabolic
genes. With regards to pathways that have been annotated in the model, Salb-GEM has
demonstrably less reactions related to carbohydrate metabolism and secondary metabolic
pathways but more so in relation to lipid metabolism.
Because S. albus has been remarked for its tendency to reduce the number of gene
paralogues [7], there may as a result be a possible impact on the number of genes that
are essential for viability, as lacking isoenzymes to catalyze reactions that are essential for
viability would result in more essential genes. Therefore, we performed gene essentiality
analysis with both Salb-GEM and Sco-GEM, and this revealed that Salb-GEM only has
marginally more essential genes (185) than Sco-GEM (180) when set to grow on glucose
minimal media, seemingly contradicting the reduced paralogues postulation. While a
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majority of the essential genes were associated with a common set of reactions in both
organisms, certain genes were predicted to be uniquely essential for each organism, and
their associated reactions were in distinct pathways (Tables S2 and S3).
More precisely, and in accordance with the reduced paralogues postulation, there were
77 reactions (Table S2) in Salb-GEM that have associations with an essential gene (which
may be part of a complex but do not possess paralogues or isozymes) while the correspond-
ing reaction relates to at least one paralogue in Sco-GEM. For instance, Salb-GEM possesses
no paralogues for the 3-oxoacyl-(acyl carrier protein) synthase (XNR_4509), an important
component responsible for the chain elongation step in fatty acid biosynthesis, but the
same reaction in Sco-GEM is associated to four isozymes (SCO0548, SCO1266, SCO2390
and SCO3248). This gene alone is associated with 41 distinct metabolic reactions as each
reaction corresponds to various degrees of saturation on the acyl moiety. Another exam-
ple of differences in absence of paralogues is observed towards the end of the shikimate
pathway, where the metabolic reactions mediated by 5-enolpyruvylshikimate-3-phosphate
synthase, chorismate mutase, prephenate dehydrogenase and anthranilate phosphoribosyl-
transferase were associated with single genes in Salb-GEM unlike in Sco-GEM. Conversely,
a total of 11 essential genes in Sco-GEM (associated to 29 reactions; Table S3) had paralogues
to their Salb-GEM genes. The gene SCO6467 encoding for phosphatidylserine synthase in
glycerophospholipid biosynthesis is essential in Sco-GEM, but its corresponding metabolic
reaction in Salb-GEM is associated to two genes. Together, while the incidence of essential
Salb-GEM genes with paralogues in Sco-GEM was twice higher than vice versa, sufficient
cases could be found where the minimized genome of Salb-GEM still yielded more par-
alogues. This indicates that the reduced paralogue postulation is not necessarily true on a
per-gene basis.
Beyond focusing on essential genes, it is feasible that the reduction in paralogues is not
only associated with essential but also non-essential reactions and processes. For instance,
nitrate reductase NarG is associated with only one gene cluster in S. albus while there are
three known operons in S. coelicolor [7], while the activity of the narG genes is predicted
to not be vital for growth. When systematically evaluating all gene-associated reactions
in the GEMs of both species, 34.6% and 37.4% of those had gene associations involving
paralogues in respectively Salb-GEM and Sco-GEM. The smaller genome in S. albus has
indeed resulted in a somewhat reduced redundancy in isoenzymes that can catalyze the
same reaction, but this reduction seemingly affects both essential and non-essential genes
equally. Additionally, it is also noteworthy that this minimization of genetic duplicates
may be more predominant in the context of regulation. The S. albus genome was reported
to code for 35 sigma factors, which is smaller relative to the 65 sigma factors employed
by S. coelicolor. The majority of these are of extra-cytoplasmic function, being responsible
for responses to external stimuli such as stresses and used for morphology such as aerial
mycelium development [7].
It is important to note that the biomass representation in Salb-GEM is partially derived
from the S. coelicolor model due to the lack of available information on S. albus biomass
composition. Any future curation of the biomass representation in Salb-GEM would have
the potential to affect the results of gene essentiality analysis, however, it is anticipated
that the complete description of S. albus biomass would not deviate drastically from that
of S. coelicolor. Moreover, while certain macromolecular components such as the cell
wall precursors may not have been experimentally determined for the organism, S. albus-
specific gene associations were found for the synthesis of glycerol teichoic acid (contributing
towards the formation of the bacterial cell wall) through manual curation [7].
2.5. Design Strategies for Improved Compound Production in S. albus
As S. albus is used for production of endogenous and heterologous compounds, it
would be imperative for Salb-GEM to be able be used to design genetic strategies to im-
prove productivity. Therefore, we applied flux scanning with enforced objective function
(FSEOF) [33], an algorithm that identifies reactions as targets for modulation of gene
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expression based on the relationship of flux through the reaction and an incrementally
increased flux towards compound production. Typically, genes associated with reactions
that positively correlate to compound production are identified as potential targets for
overexpression. The strength of this correlation, reflected by the slope in the FSEOF anal-
ysis (Table S4), is indicative of how beneficial the overexpression will be for improved
compound production.
To query a range of potential products, we selected three compounds related to the
endogenous BGCs in S. albus for FSEOF analysis, namely paulomycin, antimycin and
candicidin, in addition to two heterologous natural products, namely the thiodepsipeptide
thiocoraline [9] originating from Micronospora actinomycetes and naringenin, a flavanone
from which can be derived a majority of flavonoid compounds [34].
When considering the various genetic targets that were predicted by FSEOF to increase
productivity, subsets of various common genes were predicted for different combinations
of the five endogenous and heterologous compounds. Ten genetic targets were identified
as positively affecting all product compounds, of which seven targets covered the majority
of the shikimate pathway (i.e., biosynthesis of aromatic amino acids L-phenylalanine,
L-tyrosine and L-tryptophan), and the remaining three targets were associated with the
pentose phosphate pathway. It is worth to note that the three reactions of the pentose
phosphate pathway are responsible for the availability of erythrose 4-phosphate, which
along with phosphoenolpyruvate from the glycolytic pathway is the direct precursor to
the first metabolic reaction step of the shikimate pathway via the 3-deoxy-D-arabino-
heptulosonate 7-phosphate synthetase.
Considering the structure of each target compound (Figure 3a), which contains a
myriad of aromatic moieties, it can be anticipated that all target compounds benefit from
an increased expression of the shikimate pathway, as each of the targets counts chorismate
among its precursors. For example, the biosynthesis of the antibacterial paulomycin
converts chorismate to 2-amino-2-deoxyisochorismate as the first step in the pathway. In
the cases of thiocoraline and the antifungal antimycin, the chorismate branches off towards
synthesis of threonine and tryptophan. For the synthesis of the antifungal candicidin, the
chorismate is converted into the 4-aminobenzoate, which is also a precursor to folate. Lastly,
the heterologous production of naringenin utilizes tyrosine or phenylalanine depending
on which exogenous enzyme is used. This can be seen where the enzymes chorismate
mutase, prephenate dehydrogenase and tyrosine transaminase are uniquely predicted for
the improved production of naringenin (Figure 3b).
In addition, significant overlap across multiple compounds could be observed as
genetic targets that function in fatty acid biosynthesis. The production of paulomycin,
naringenin and candicidin which draw fatty acyl-CoA precursors (e.g., crotonyl-CoA and
malonyl-CoA) from primary metabolism, would benefit from the overexpression of fatty
acid biosynthetic genes. This can likely be further extrapolated to all polyketide secondary
metabolites that draw heavily from these precursors. In the case of naringenin and can-
dicidin, which both utilize malonyl-CoA as precursor, among the overexpression targets
carrying the most flux was acetyl-CoA carboxylase, a reaction that converts acetyl-CoA
to malonyl-CoA by condensation [35,36]. Indeed, in the context of naringenin, malonyl-
CoA been cited as the predominant limiting factor in further production of flavonoid
compounds [19,20,37].
While the targets share many common reactions in the shikimate pathway and fatty
acid biosynthesis, there is also a myriad of unique targets that differ starkly in regard to
their associated pathways such as the previously mentioned overexpression of prephenate
dehydrogenase (XNR_5061) to convert chorismate to L-tyrosine, a precursor leading to
naringenin. With regards to another instance, in order to augment the availability of the L-
paulomycose moiety on the basic paulomycin structure, many suggested targets originate
from purine and pyrimidine metabolism.
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details on reaction name, pathway and slope can be found in Table S3. (b) simplified view of pathways branching off from
the shikimate pathway towards individual product targets. Each product draws from chorismate as a precursor.
For other compounds such as thiocoraline that draw heavily from L-cysteine as a build-
ing block, suggested targets also encompass cysteine and sulfur metabolism such as sulfate
adenyltransferase (XNR_0714 and XNR_0715) and adenylyl-sulfate kinase (XNR_0713).
Other compounds that are produced from endogenous BGCs such as ca dicidin also reflect
t role that fatty acid precursors have in limiti g overall yields. For instance, in order
to imp ve precursor flux towards candicidi biosy thesis, the (R)-Methylmalonyl-CoA
CoA-carbonylmutase (XNR_4666) n methylmalonyl-CoA epimerase (XNR_1439) are
beneficial enzymes to overexpress.
Of the various predicted overexpression targets, few have been reportedly tested to
increase production formation in S. albus. Interestingly, the overexpression of acetyl-CoA
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carboxylase, beneficial for both naringenin and candicidin production according Salb-
GEM, has been investigated in S. albus for increased production of the flavonol myricetin,
which has naringenin as a precursor. Subunits of the acetyl-CoA carboxylase complex
from S. coelicolor were heterologously expressed in S. albus [20]. As the complex converts
acetyl-CoA to malonyl-CoA, higher productivity of myricetin was anticipated. Indeed,
flavonol production increased, but not in the form of myricetin but rather in the detec-
tion of the shunt product apigenin. This highlights that the FSEOF approach is solely
based on the metabolic network stoichiometry and does not factor in modes of regula-
tion. Meanwhile, overexpression of the tyrA and aroG genes in Escherichia coli, coding
for chorismate synthase/prephenate dehydrogenase (CHORM and PPND) and 3-deoxy-
D-arabino-heptulosonate 7-phosphate synthetase (DDPA), yielded increased naringenin
production [38]. While FSEOF applied to Salb-GEM indeed provides effective strategies
to facilitate precursor flux from primary metabolism, an important limitation remains the
limited detailed information that is available of the heterologous pathway themselves,
precluding inclusion in the model.
3. Materials and Methods
3.1. Model Reconstruction
3.1.1. Homology-Based Reconstruction
The genome-scale metabolic network reconstruction for S. albus J1074 was based on
published genome annotation (GenBank: CP004370.1, NCBI: PRJNA180996) and carried
out using the RAVEN Toolbox [24,25]. By referencing the most up-to-date and complete
GEM of S. coelicolor, Sco-GEM [23], as a template model, the first draft of the GEM was
created by assigning reactions based on protein homology. This was performed by running
the RAVEN function getModelFromHomology, which utilizes the data structure from a
bi-directional homology search via BLASTp and assigns the best-fitting GPRs using the
following parameters as cut-offs: a maximum E-value of 10−50, a minimum alignment
length of 90 residues and a minimum identity of 40%. These values for the parameters have
been selected in order to incorporate the reactions essential for various growth phenotypes
and minimize the number of reactions added by the gap-filling process in later steps. Any
spontaneous reactions or transport reactions with no gene-association were also imported
from the Sco-GEM template model.
3.1.2. Definition of Biomass Composition and Energetic Parameters
Where no experimental data was available for biomass components in S. albus, it
was assumed that these would not deviate drastically from S. coelicolor. Therefore, the
storage carbohydrate, cell wall and lipid components of the biomass reaction were taken
from Sco-GEM, while the stoichiometric coefficients of ribonucleotides, nucleotides and
amino acids were inferred from the S. albus genome and coding sequences. The DNA and
protein content were determined from cultivations reported in this work, while also the
energetic parameters GAEC and NGAM were taken from these. While the experimental
data only allowed for determining the sum of GAEC and NGAM, the NGAM was set at
6.86 mmol/gDCW/h in agreement with the model prokaryotic GEM of Escherichia coli,
resulting with a GAEC of 173 mmol/gDCW.
3.1.3. Gap-Filling
To yield a functional model, gap-filling was performed using RAVEN function fillGaps
to retrieve the minimum set of reactions from Sco-GEM to ensure that the model can grow
in silico. After the initial gap-filling, the model was evaluated for growth solely on other
carbon sources (e.g., fructose, xylose, and mannitol). For substrates that are known to
support S. albus growth but the phenotype with which could not be replicated in silico, the
minimum number of reactions were added from the template model to support utilization
of the designated substrate. For latter substrates, manual gap-filling was performed by
adding reactions that carried flux in Sco-GEM solely utilizing the corresponding substrates
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to the draft model; any new reactions that did not carry flux in the model were subsequently
removed. Additional reactions were incorporated from another draft model generated
from KEGG via RAVEN function getKEGGModelForOrganism, which utilizes HMMER
in homology search and queries the S. albus proteome against KEGG orthology (KO)-
trained hidden Markov models (HMMs). The additional reactions were checked to not be
associated with any genes already included in the previous draft model.
3.1.4. Curation of Reaction Reversibility
Reactions added from this and later steps were subsequently curated for directionality.
eQuilibrator [39] was used to determine reversibility for the additional reactions based on
computed Gibbs free energy values at standard conditions (25 ◦C, 1 bar), pH7 and 1mM
concentration of reactants. A threshold of −30 kJ/mol was applied to define a reaction
as irreversible. For any cases wherein the Gibbs free energy could not be calculated (e.g.,
primarily from metabolites not recognized by the API), the reactions were curated manually
by checking that they do not contribute to any futile cycles.
3.1.5. Model Distribution
The development and curation of Salb-GEM is reproducibly tracked and freely avail-
able from https://www.github.com/SysBioChalmers/Salb-GEM (accessed on 21 April
2021), and archived on Zenodo (https://doi.org/10.5281/zenodo.3693405 (accessed on 21
April 2021)). The model is versioned, and release 1.0.1 was used in the analyses presented
here. The model is distributed in SBML L3V1 FBCv2 format, while an overview of the
reactions in version 1.0.1 is also shown in Table S1.
3.2. Model Analysis
Within the feasible solution space at steady-state, it is possible to further identify
specific points (e.g., flux distributions) that satisfy certain conditions specified as objective
functions to be either maximized or minimized. In most cases, this objective function is
based on the biomass reaction representing the organism’s main goal to grow as fast as
possible. A commonly used mathematical method to analyze metabolic network recon-
structions is flux balance analysis (FBA), which calculates the flow, or flux, of metabolites
through the metabolic network, enabling prediction of an organism’s growth rate or pro-
duction rate of a desired metabolite.
Gene essentiality analysis was carried out using the singleGeneDeletion function on
COBRA Toolbox [40]. Essential genes were determined by comparing the in silico growth
rate of the gene knockout mutant with that of the wild-type strain. Any gene of which the
knockout consequently leds to a reduction in the growth prediction by two-thirds or more
if not leading to no growth entirely (e.g., an infeasible problem) is categorized as essential.
Potential targets for metabolic engineering towards improved yield of natural products
were predicted by using flux scanning with enforced objective function (FSEOF) [33]. The
method works by scanning all metabolic fluxes in the GEM and prioritizing fluxes that
increase when the flux towards product is enforced as a constraint during flux balance
analysis while maximizing biomass formation flux as well.
3.3. Cultivation and Data Collection
Triplicate cultures of S. albus J1074 were grown in shake flasks with 100 mL of NL333
medium [5] over a duration of 72 h, using an inoculum of 108 CFU/mL. Samples were taken
every 6 h for glucose concentrations as determined using glucose oxidase colorometric
assay (GAGO-20, Sigma-Aldrich, Gillingham, UK) following manufacturer’s instructions;
biomass determined as dry cell weight, protein content by Bradford assay as previously
described [19] and DNA concentration by Burton method [41].
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4. Conclusions
Here we present the first genome-scale metabolic model (GEM) for Streptomyces albus
J1074, which can be used in constraint-based analysis. We demonstrated utility of the model
in identifying sets of shared targets that may be tested to improve endogenous and heterol-
ogous production in S. albus. Additionally, we have used the model to glean insights into
the effect of the S. albus minimal genome on its metabolism, comparing the existence of par-
alogues between S. albus and S. coelicolor and the resulting impact on gene essentiality. The
Salb-GEM model was able to provide realistic growth predictions in comparison with exper-
imentally measured growth and glucose consumption rates. However, the model would
benefit from a more detailed description of the S. albus biomass composition, evidence of
gene essentiality and general fermentation data. When such relevant experimental data will
become available, the model can readily be curated and further improved. Open and repro-
ducible model curation and distribution of an updated model are facilitated by continually
hosting the model on GitHub (https://www.github.com/SysBioChalmers/Salb-GEM (ac-
cessed on 21 April 2021)), where the research community can transparently reference,
reproduce and contribute to the model curation and development.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/metabo11050304/s1, Table S1: Metabolic reactions and their gene association as represented
in Salb-GEM. Table S2: Metabolic reactions in Salb-GEM and Sco-GEM associated with essential
genes predicted in Salb-GEM with multiple paralogues in Sco-GEM, Table S3: Metabolic reactions
in Salb-GEM and Sco-GEM associated with essential genes predicted in Sco-GEM with multiple
paralogues in Salb-GEM. Table S4: Summary of predicted FSEOF targets sorted by product of interest.
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